Différences entre versions de « Arthropathies »
De médecine.top
(→Goutte) |
(→Goutte) |
||
| Ligne 21 : | Ligne 21 : | ||
** For patients with severe and refractory attacks, or with contraindications to other treatments, off-label use of IL-1 inhibitors (anakinra or canakinumab) can be considered. | ** For patients with severe and refractory attacks, or with contraindications to other treatments, off-label use of IL-1 inhibitors (anakinra or canakinumab) can be considered. | ||
* <u>Traitement hypo-uricémiant:</u> | * <u>Traitement hypo-uricémiant:</u> | ||
| − | ** '''Xanthine oxidase inhibitors''' | + | ** '''Xanthine oxidase inhibitors''' → reduce urate production: '''allopurinol''', '''fébuxostat''' ([https://compendium.ch/product/1327720-adenuric-cpr-pell-80-mg Adénuric]) |
** '''Uricosuric agents''' (decrease renal urate resorption) | ** '''Uricosuric agents''' (decrease renal urate resorption) | ||
** '''Pegloticase''' (a uricase). | ** '''Pegloticase''' (a uricase). | ||
Version du 13 juin 2020 à 14:55
Arthrose
- Caractéristiques radiologiques:
- Pincement articulaire
- Sclérose sous-chondrale
- Ostéophytes
- Géodes
- Traitement: AINS, chirurgical (remplacement prothétique).
- Arthrose du genou: duloxétine. Injection intra-articulaire de glucocorticoïdes ou d'acide hyaluronique dans l'arthrose du genou et de la hanche. Pas de bénéfice du paracétamol dans l'arthrose de la hanche et du genou.
Arthrites microcristallines
Chondrocalcinose
- Synonyme: pseudogoutte
Déposition de cristaux de pyrophosphate de calcium
Goutte
- Traitement de la crise de goutte:
- Colchicine The simplest is colchicine, 1.2 mg at the first symptoms of a gout attack, followed 1 hour later by a 0.6-mg dose. Colchicine is most effective when used early in attacks (<24 hours after onset) and is less useful when the attack is well established.
- AINS High-dose NSAID therapy for 5 to 7 days is effective
- Glucocorticoïdes in any form—intra-articular injection, intramuscular depot injection (for example, depo-methylprednisolone, 40-80 mg), or an oral “burst” of prednisone (for example, 0.5 mg/kg/d, for 5 days).
- For patients with severe and refractory attacks, or with contraindications to other treatments, off-label use of IL-1 inhibitors (anakinra or canakinumab) can be considered.
- Traitement hypo-uricémiant:
- Xanthine oxidase inhibitors → reduce urate production: allopurinol, fébuxostat (Adénuric)
- Uricosuric agents (decrease renal urate resorption)
- Pegloticase (a uricase).
Polyarthrite rhumatoïde (PAR)
- Facteur rhumatoïde (FR) positif, anticorps anti-peptide cyclique citrulliné (anti-CCP) positif
- https://www.revmed.ch/RMS/2014/RMS-N-421/Traitement-de-fond-de-la-polyarthrite-rhumatoide
